Oncology

Metastatic Prostate Cancer @ ASCO

Advertisement

Conference Reporter® in Metastatic Prostate Cancer to Cover Key Topics Being Presented at ASCO 2025

conference reporter by Neeraj Agarwal, MD, FASCO; Jeremie Calais, MD, PhD
Overview
<p>Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in Metastatic Prostate Cancer presented at the 2025 ASCO Annual Meeting.</p> <p> </p> <p> </p> <p><strong>VIEW THE TOPICS: </strong></p> <p>•     Advancements in Targeted Therapies for Metastatic Prostate Cancer<br /> •     Biomarker-Driven Personalization in Metastatic Prostate Cancer Management<br /> •     PSMA-Targeted Radioligand Therapies for Prostate Cancer<br /> •     Radiopharmaceutical Therapy in Advanced Prostate Cancer</p> <div class="overview"> <p> </p> </div> <div class="body-content"> <p><em>This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Clinical Oncology.</em></p> </div> <p> </p> <p style="text-align: center;">2025 ASCO Annual Meeting</p> <p style="text-align: center;">May 30 – June 3, 2025</p> <p style="text-align: center;">McCormick Place, Chicago, IL & Online</p> <p style="text-align: center;"><a href="https://meetings-registration.asco.org/registration-and-housing/327/meeting_registration?intcmp=nw_ascoorg_am_am25_site_amlandingpage_all__glob_041625__qklnk__aware_image_">Link to Registration</a></p>

Neeraj Agarwal, MD, FASCO

Professor of Medicine
Presidential Endowed Chair of Cancer Research
Senior Director for Clinical Research
Director, Genitourinary Oncology Program and Center of Investigational Therapeutics
Huntsman Cancer Institute
University of Utah
Salt Lake City, UT

Jeremie Calais, MD, PhD

Associate Professor
Director, Clinical Research and Theranostics Programs
Ahmanson Translational Theranostics Division
Department of Molecular and Medical Pharmacology
Faculty Member, Jonsson Comprehensive Cancer Center and Institute for Urologic Oncology
David Geffen School of Medicine at UCLA
Los Angeles, CA

Advertisement